Publications and Presentations
1. Tonti E, Lee YM, Gruenke N, Ferren J, Stutzman DL. Impact of pharmacogenomics on pediatric psychotropic medication prescribing in an ambulatory care setting. J Child and Adolesc Psychopharmacol. 2024 Jan (accepted).
2. Aquilante C, Trinkley KE, Lee YM, Crooks KR, Hearts EC, Heckman SM, Hess KW, Kudron EL, Martin JL, Swartz CT, Kao DP. Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program. Am J Health Syst Pharm. 2024; zxae008, https://doi.org/10.1093/ajhp/zxae008.
3. Wiley LK, Shortt JA, Roberts ER, Lowery J, Kudron E, Lin M, Mayer DA, Wilson MP, Brunetti TM, Chavan S, Phang TL, Pozdeyev N, Lesny J, Wicks SJ, Moore ET, Morgenstern JL, Roff AN, Shalowitz EL, Stewart A, Williams C, Edelmann MN, Hull M, Tacker Patton J, Axell L, Ku L, Lee YM, Jirikowic J, Tanaka A, Todd E, White S, Peterson B, Hearst E, Zane R, Greene CS, Mathias R, Coors M, Taylor MRG, Kahn MG, Brooks IM, Aquilante CL, Kao D, Rafaels N, Crooks KR, Hess S, Barnes KC, Gignoux CR, Colorado Center for Personalized Medicine. Building a Vertically-Integrated Genomic Learning Health System: The Colorado Center for Personalized Medicine Biobank. Am J Hum Genet. 2024 Jan 4;111(1):11-23. PMID: 38181729
4. Kudron EL, Raghavan S, Lee YM, Lowery J. Primary care providers’ preferences for the communication and management of actionable genomic findings from a research biobank. Genetics in Medicine 2023; https://doi.org/10.1016/j.gimo.2023.100830.
5. Lee YM, Berenbrok LA, Galvez-Peralta M, Iwuchukwu O, Kisor DF, Petry NJ, Gammal RS. Advancing pharmacogenomics-based care through interprofessional education. Am J Pharm Educ. 2023 May;87(5):100007. 15. PMID: 37288681
6. Martin JL, Lee YM, Corbin LW, Colson R, Aquilante, CL. Patients’ perspectives of a pharmacist-provided clinical pharmacogenomics service. Pharmacogenomics 2022 Jun;23(8):463-474. PMID: 35469451
7. Lee CR, Luzum JA, Sangkuhl K, Gammal RS, Sabatine MS, Stein CM, Kisor DF, Limdi NA, Lee YM, Scott SA, Hulot JS, Roden DM, Gaedigk A, Caudle KE, Klein TE, Johnson JA, Shuldiner AR. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update. Clin Pharmacol Ther. 2022 Nov;112(5):959-967. PMID: 35034351
8. Ariefdjohan M, Lee YM, Stutzman DL, LeNoue S, Wamboldt MZ. The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study. Pediatric Reports. 2021 Jul 28;13(3):421-433. PMID 34449718
9. Gammal RS, Lee YM, Petry NJ, Iwuchukwu O, Hoffman JM, Kisor DF, Empey PE. Pharmacists leading the way to precision medicine: Updates to the core pharmacist competencies in genomics. Am J Pharm Educ. 2021 Jul 22:8634. PMID: 34301570.
10. Liko I, Lee YM, Stutzman DL, Blackmer AB, Reynolds AM, Deininger KM, Aquilante CL. Providers’ perspectives on the clinical utility of pharmacogenetic testing in pediatric patients. Pharmacogenomics 2021 Apr;22(5):263-274. PMID: 33657875
11. Liko I, Corbin, L, Tobin E, Aquilante CL, Lee YM*#. Implementation of a pharmacist-provided pharmacogenomics service in an Executive Health Program. Am J Health System Pharm. 2021 Jun 7;78(12):1094-1103. PMID: 33772264
12. Gammal R, Nguyen J, Audi E, Lee YM, Petry N, Empey P. Advanced Pharmacy Practice Experiences in Pharmacogenomics Offered by US Pharmacy Programs. Am J Pharm Educ. 2020 Dec;84(12):ajpe8031. PMID: 34283786
13. Deininger KM, Tsunoda SN, Hirsch JD, Anderson H, Lee YM, Mcllvennan CK, Page II RL, Tran JN, Aquilante CL. National survey of physicians’ perspectives on pharmacogenetic testing in solid organ transplantation. Clinical Transplantation 2020 Jul 12;e14037. PMID: 32654213
14. Aquilante CL, Kao DP, Trinkley KE, Lin CT, Crooks KR, Hearst E, Hess SJ, Kudron EL, Lee YM, Liko I, Lowery J, Mathias RA, Monte AA, Rafaels N, Rioth MJ, Roberts ER, Williamson C, Barnes KC. Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience. Pharmacogenomics 2020 Apr;21(6):375-386. PMID: 32077359
15. Liko I, Lai E, Griffin RJ, Aquilante CL, Lee YM*#. Patients’ Perspectives on psychiatric pharmacogenetic testing. Pharmacopsychiatry 2020 Nov;53(6):256-261. PMID 32583391
16. Deininger KM, Tran JN, Tsunoda SM, Young GK, Lee YM, Anderson HD, Page RL II, Hirsch JD, Aquilante CL. Stakeholder Perspectives of the Clinical Utility of Pharmacogenomic Testing in Solid Organ Transplantation. Pharmacogenomics 2019 Dec;20(18):1291-1302. PMID: 31755847
17. Lee YM, Danahey K, Knoebel TW, Ratain MJ, Meltzer DO, O’Donnell PH, Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing. Pharmacogenet Genomics. 2019 Feb;29(2):23-30. PMID 30531378
18. Deininger KM, Page RL 2nd, Lee YM, Kauffman YS, Johnson SG, Oreschak K, Aquilante CL. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine. Per Med. 2019 Mar;16(2):123-132. PMID 30543145
19. Lee YM, Manzoo BS, Cavallari LH, Nutescu EA. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner City Population. Pharmacotherapy 2018 Feb;38(2):205-216. PMID 29286540
20. Cavallari LH, Lee CR, Beitelshees AL, Cooper-DeHoff RM, Duarte JD, Voora D, Kimmel SE, McDonough CW, Gong Y, Dave CV, Pratt VM, Alestock TD, Anderson RD, Alsip J, Ardati AK1 Brott BC, Brown L, Chumnumwat S, Clare-Salzler MJ, Coons JC, Denny JC, Dillon C, Elsey AR, Hamadeh IS, Harada S, Hillegass WB, Hines L, Horenstein RB, Howell LA, Jeng LJB, Kelemen MD, Lee YM, Magvanjav O, Montasser M, Nelson DR, Nutescu EA, Nwaba DC, Pakyz RE, Palmer K, Peterson JF, Pollin TI, Quinn AH, Robinson SW, Schub J, Skaar TC, Smith DM, Sriramoju VB, Starostik P, Stys TP, Stevenson JM, Varunok N, Vesely MR, Wake DT, Weck KE, Weitzel KW, Wilke RA, Willig J, Zhao RY, Kreutz RP, Stouffer GA, Empey PE, Limdi NA, Shuldiner AR, Winterstein AG, Johnson JA; IGNITE Network. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC Cardiovasc Interven. JACC Cardiovasc Interv. 2018 Jan 22;11(2):181-191. PMID 29102571
21. Lee YM, McKillip RP, Borden BA, Klammer CE, Ratain MJ, O’Donnell PH. Assessment of patient perceptions of genomic testing to inform pharmacogenomics implementation. Pharmacogenet. Genomics. 2017 May;27(5):179-189. PMID 28267054
22. Hussain S, Kenigsberg BB, Danahey K, Lee YM, Galecki PM, Ratain MJ, O’Donnell PH. Disease-drug database for pharmacogenomic-based prescribing. Clin. Pharmacol. Ther. 2016 Aug;100(2):179-90. PMID 26940584
Review articles and Case Reports
1. Putra M, Lee YM, Bucholz E, Ross E, Galan H, Behrendt N, Micke K, Chow FS, Zaretsky MV, Cuneo BF, Successful management of fetal torsades de pointes and long QT syndrome by a cardio-obstetrical team. JACC Case Rep. 2023 Dec 6;27:102110. PMID 38094730
2. Miller MA, Lee YM. Applying pharmacogenomics to antifungal selection and dosing: are we there yet? Current Fungal Infection Reports 2020 Mar;14(1):63-75. PMID: 32256938
3. Chang JT-H, Lee YM, Huang RS. The impact of the cancer genome atlas on lung cancer. Transl. Res. 2015 Dec;166(6):568-85. PMID 26318634
4. Ismail S, Lee YM, Patel M, Duarte JD, Ardati AK. Genotype- and phenotype-directed antiplatelet therapy selection in patients with acute coronary syndromes. Expert Rev Cardiovasc Ther. 2014 Nov;12(11):1289-303. PMID: 25340283
5. Lee YM, Eggen J, Soni V, Drozda K, Nutescu EA, Cavallari LH. Warfarin dose requirements in a patient with the CYP2C9*14 allele. Pharmacogenomics. 2014 May;15(7):909-14. PMID: 24956244
